Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of new oral anticoagulants
and vitamin K antagonists for the anticoagulation for the implantation of vena cava filters
in patients with deep venous thrombosis.
Phase:
Phase 3
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
Anhui Provincial Hospital Huadong Hospital Shanghai 5th People's Hospital Shanghai Zhongshan Hospital Sir Run Run Shaw Hospital Yantai Yuhuangding Hospital